These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9837771)

  • 1. Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels.
    Kuo YM; Emmerling MR; Bisgaier CL; Essenburg AD; Lampert HC; Drumm D; Roher AE
    Biochem Biophys Res Commun; 1998 Nov; 252(3):711-5. PubMed ID: 9837771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.
    Attems J; Jellinger KA; Lintner F
    Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype.
    Fagan AM; Younkin LH; Morris JC; Fryer JD; Cole TG; Younkin SG; Holtzman DM
    Ann Neurol; 2000 Aug; 48(2):201-10. PubMed ID: 10939571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
    Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
    Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma cholesterol does not affect brain Abeta in mice lacking the low-density lipoprotein receptor.
    Elder GA; Cho JY; English DF; Franciosi S; Schmeidler J; Sosa MA; Gasperi RD; Fisher EA; Mathews PM; Haroutunian V; Buxbaum JD
    J Neurochem; 2007 Aug; 102(4):1220-31. PubMed ID: 17472705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease.
    Raygani AV; Rahimi Z; Kharazi H; Tavilani H; Pourmotabbed T
    Neurosci Lett; 2006 Nov; 408(1):68-72. PubMed ID: 16997467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distribution of cerebrovascular amyloid in Alzheimer's disease varies with ApoE genotype.
    Trembath D; Ervin JF; Broom L; Szymanski M; Welsh-Bohmer K; Pieper C; Hulette CM
    Acta Neuropathol; 2007 Jan; 113(1):23-31. PubMed ID: 17089130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model.
    Mann KM; Thorngate FE; Katoh-Fukui Y; Hamanaka H; Williams DL; Fujita S; Lamb BT
    Hum Mol Genet; 2004 Sep; 13(17):1959-68. PubMed ID: 15229191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
    Cubrilo-Turek M; Sertić J; Duraković Z
    Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
    Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
    Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease: the cholesterol connection.
    Puglielli L; Tanzi RE; Kovacs DM
    Nat Neurosci; 2003 Apr; 6(4):345-51. PubMed ID: 12658281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease.
    Lewczuk P; Esselmann H; Groemer TW; Bibl M; Maler JM; Steinacker P; Otto M; Kornhuber J; Wiltfang J
    Biol Psychiatry; 2004 Mar; 55(5):524-30. PubMed ID: 15023581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
    Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
    Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A polymorphism in lipoprotein lipase affects the severity of Alzheimer's disease pathophysiology.
    Blain JF; Aumont N; Théroux L; Dea D; Poirier J
    Eur J Neurosci; 2006 Sep; 24(5):1245-51. PubMed ID: 16965549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.
    Attems J; Lintner F; Jellinger KA
    Acta Neuropathol; 2004 Apr; 107(4):283-91. PubMed ID: 14986026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Abeta homeostasis in AD and DS: impairment of anti-amyloidogenic protection by lipoproteins.
    Matsubara E; Sekijima Y; Tokuda T; Urakami K; Amari M; Shizuka-Ikeda M; Tomidokoro Y; Ikeda M; Kawarabayashi T; Harigaya Y; Ikeda S; Murakami T; Abe K; Otomo E; Hirai S; Frangione B; Ghiso J; Shoji M
    Neurobiol Aging; 2004 Aug; 25(7):833-41. PubMed ID: 15212837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.